Cohort 9

NamiDiagnostics

WEBSITE

NaMi Diagnostics is developing a new generation of rapid, cell-based diagnostics for the early detection of sepsis. Using proprietary technologies that analyze neutrophil properties from small blood samples, NaMi aims to provide clinicians with faster, more accurate insight into immune responses to infection. Their portable, point-of-care diagnostic system is designed to improve patient outcomes while reducing unnecessary antibiotic use and false-positive diagnoses.

Highlight Video

The Team

Dr. Ke Liu, Founder

Dr. Dimitri Pappas, Founder

McKenna McKay, Founder

Houngyu Pu, Founder

 

The Mentors

Jeff Mustin, Lead

Lena Zappia

Robert Mamlock

Phil Sizer

Kevin Soules

Carrie Shaver

Mike Murphy

Jessica Kelly

Courtney Queen

Gilbert Valdez, Speciality

Nick Bergfeld, Executive Coach